A detailed history of Sarasin & Partners LLP transactions in Pfizer Inc stock. As of the latest transaction made, Sarasin & Partners LLP holds 1,089,401 shares of PFE stock, worth $29.9 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,089,401
Previous 1,111,179 1.96%
Holding current value
$29.9 Million
Previous $31.1 Million 1.41%
% of portfolio
0.3%
Previous 0.28%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$27.7 - $31.39 $603,250 - $683,611
-21,778 Reduced 1.96%
1,089,401 $31.5 Million
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $7.43 Million - $8.7 Million
-293,956 Reduced 20.92%
1,111,179 $31.1 Million
Q1 2024

Apr 12, 2024

BUY
$25.89 - $29.73 $582,628 - $669,043
22,504 Added 1.63%
1,405,135 $39 Million
Q4 2023

Jan 09, 2024

BUY
$26.13 - $33.94 $25.3 Million - $32.9 Million
969,973 Added 235.05%
1,382,631 $39.8 Million
Q3 2023

Oct 05, 2023

SELL
$32.09 - $37.51 $5.01 Million - $5.86 Million
-156,199 Reduced 27.46%
412,658 $13.7 Million
Q2 2023

Jul 10, 2023

BUY
$36.12 - $41.79 $3.81 Million - $4.4 Million
105,357 Added 22.73%
568,857 $20.9 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $260,052 - $338,550
6,602 Added 1.44%
463,500 $18.9 Million
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $825,535 - $1.07 Million
20,958 Added 4.81%
456,898 $18.6 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $376,251 - $491,154
9,012 Added 2.11%
435,940 $22.3 Million
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $403,948 - $493,120
9,231 Added 2.21%
426,928 $18.7 Million
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $634,436 - $752,242
13,635 Added 3.37%
417,697 $21.9 Million
Q1 2022

Apr 11, 2022

SELL
$45.75 - $56.69 $2.41 Million - $2.98 Million
-52,639 Reduced 11.53%
404,062 $20.9 Million
Q4 2021

Jan 19, 2022

SELL
$41.32 - $61.25 $6.15 Million - $9.12 Million
-148,828 Reduced 24.58%
456,701 $27 Million
Q3 2021

Oct 22, 2021

SELL
$39.25 - $50.42 $3,611 - $4,638
-92 Reduced 0.02%
605,529 $26 Million
Q2 2021

Jul 13, 2021

SELL
$35.91 - $40.68 $55,624 - $63,013
-1,549 Reduced 0.26%
605,621 $23.7 Million
Q1 2021

Apr 29, 2021

SELL
$33.49 - $37.77 $13.4 Million - $15.1 Million
-399,599 Reduced 39.69%
607,170 $22 Million
Q4 2020

Jan 19, 2021

SELL
$33.47 - $42.56 $20.6 Million - $26.2 Million
-614,686 Reduced 37.91%
1,006,769 $37.1 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $4.82 Million - $5.66 Million
-151,923 Reduced 8.57%
1,621,455 $59.5 Million
Q2 2020

Jul 17, 2020

SELL
$30.12 - $36.54 $69.2 Million - $83.9 Million
-2,297,223 Reduced 56.43%
1,773,378 $58 Million
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $4.77 Million - $6.82 Million
-176,534 Reduced 4.16%
4,070,601 $133 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $4.73 Million - $5.37 Million
-143,634 Reduced 3.27%
4,247,135 $166 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $5.86 Million - $7.6 Million
180,473 Added 4.29%
4,390,769 $158 Million
Q2 2019

Jul 18, 2019

BUY
$36.98 - $41.52 $1.51 Million - $1.69 Million
40,813 Added 0.98%
4,210,296 $182 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $1.17 Million - $1.28 Million
31,075 Added 0.75%
4,169,483 $177 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $932,512 - $1.06 Million
-24,240 Reduced 0.58%
4,138,408 $181 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $15.6 Million - $18.9 Million
-452,989 Reduced 9.81%
4,162,648 $183 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $2.3 Million - $2.45 Million
69,794 Added 1.54%
4,615,637 $167 Million
Q1 2018

May 01, 2018

SELL
$31.91 - $37.02 $14.5 Million - $16.8 Million
-453,331 Reduced 9.07%
4,545,843 $161 Million
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $1.86 Million - $1.97 Million
55,921 Added 1.13%
4,999,174 $181 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $153 Million - $169 Million
4,943,253
4,943,253 $176 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sarasin & Partners LLP Portfolio

Follow Sarasin & Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.